Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 1% | 8.2% | 15.1% |
| Success rate | 100% | 68% | 82% |
| Transactions |
4
25% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Executive Officer, Managing Director | SeQuent Scientific Ltd | Nov. 12, 2014 - |
| Chief Executive Officer | SeQuent Scientific Ltd | Jan. 1, 2014 - Nov. 12, 2014 |
| Chief Executive Officer - Pharma | Strides Pharma Science Ltd | None - |
Search